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Hypertension in pregnancy is common, occurring in ≤10% of all pregnancies with ≤20% of those women hav-
ing preeclampsia. Treatment approaches of “less tight” and 
“tight” control of chronic or gestational hypertension can be 
found in international guidelines for management of hyperten-
sion in pregnancy.1
To understand the effects of these contrasting approaches, 
we undertook an open, multicenter international randomized 
controlled trial. The study is described elsewhere,2 but briefly, 
987 consenting women were enrolled between March 26, 2009 
and August 2, 2012 at centers confirmed to have capacity to pro-
vide the necessary maternal and neonatal care. Eligible women 
Abstract—The CHIPS randomized controlled trial (Control of Hypertension in Pregnancy Study) found no difference in the 
primary perinatal or secondary maternal outcomes between planned “less tight” (target diastolic 100 mm Hg) and “tight” 
(target diastolic 85 mm Hg) blood pressure management strategies among women with chronic or gestational hypertension. 
This study examined which of these management strategies is more or less costly from a third-party payer perspective. A 
total of 981 women with singleton pregnancies and nonsevere, nonproteinuric chronic or gestational hypertension were 
randomized at 14 to 33 weeks to less tight or tight control. Resources used were collected from 94 centers in 15 countries 
and costed as if the trial took place in each of 3 Canadian provinces as a cost-sensitivity analysis. Eleven hospital ward and 
24 health service costs were obtained from a similar trial and provincial government health insurance schedules of medical 
benefits. The mean total cost per woman–infant dyad was higher in less tight versus tight control, but the difference in 
mean total cost (DM) was not statistically significant in any province: Ontario ($30 191.62 versus $24 469.06; DM $5723, 
95% confidence interval, −$296 to $12 272; P=0.0725); British Columbia ($30 593.69 versus $24 776.51; DM $5817; 
95% confidence interval, −$385 to $12 349; P=0.0725); or Alberta ($31 510.72 versus $25 510.49; DM $6000.23; 95% 
confidence interval, −$154 to $12 781; P=0.0637). Tight control may benefit women without increasing risk to neonates 
(as shown in the main CHIPS trial), without additional (and possibly lower) cost to the healthcare system.
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1050  Hypertension  October 2016
were between 14 weeks 0 days and 33 weeks 6 days of gesta-
tion and had a live fetus, nonproteinuric chronic or gestational 
hypertension, an office diastolic blood pressure (BP) of 90 to 
105 mm Hg (or 85–105 mm Hg if antihypertensive medica-
tion was being taken), and had no exclusion criteria, including 
a systolic BP of ≥160 mm Hg systolic or proteinuria. Women 
were randomized to less tight BP control (target diastolic BP of 
100 mm Hg) or tight control (target diastolic BP of 85 mm Hg) 
until delivery, with labetalol as the drug of first choice. The 
primary composite outcome (pregnancy loss or high-level neo-
natal care for more than 48 hours) was similar between groups 
(adjusted odds ratio [aOR], 1.02; 95% confidence interval [CI], 
0.77–1.35). The secondary outcome of serious maternal com-
plications ≤6 weeks postpartum or until hospital discharge was 
not significantly different (aOR, 1.74; 95% CI, 0.79–3.84). 
At the prespecified 99.9% significance level for the second-
ary analysis of maternal outcomes adjusted for stratification 
factors, 40.6% of women in the less tight group experienced 
postrandomization severe hypertension compared with 27.5% 
in the tight control group (aOR, 1.80; 95% CI, 1.34–2.38). At 
the 95%, but not at the prespecified 99.9%, significance level, 
4.3% of less tight compared with 1.6% of tight women had 
thrombocytopenia (platelet count <100×109; aOR, 2.63; 95% 
CI, 1.15–6.05), and 4.3% compared with 1.8%, respectively, 
had elevated aspartate aminotransferase or alanine aminotrans-
ferase levels with symptoms (aOR, 2.33; 95% CI, 1.05–5.16), 
indicating a positive impact for women in the tight control 
group. The current analysis was planned to determine the cost 
to the healthcare system related to less tight compared with 
tight BP control of pregnancy hypertension to inform resource 
allocation decisions and policy.
Methods
Ethics approval for the trial and cost analysis was obtained from the 
trial coordinating center (University of British Columbia Clinical 
Research Ethics Board, H08-00882) and at each recruiting center. 
Informed consent was obtained from each woman before enrollment. 
The cost analysis was undertaken from the perspective of a third-
party payer (eg, Ministry of Health) as if all the study participants had 
received care in each of 3 Canadian provinces (ie, Ontario, British 
Columbia, and Alberta) to provide a sensitivity analysis of different 
price structures on the robustness of cost outcomes and to enhance 
generalizability. The study included 3 provinces that represented 63% 
(21.84 million people) of Canada’s population3 and 62.3% of total 
public sector health expenditure in Canada in 2013,4 and share similar 
provincial government-funded healthcare systems, including funding 
structures for nurses and hospitals and fee-for-service or salaries for 
physicians. Outcomes included the difference in mean cost between 
tight and less tight groups of: the total cost of 24 services in each 
province, total cost of 11 hospital ward durations, and overall total 
cost of all services and ward durations in each province. All costs 
are presented in 2013 Canadian dollars, the year that the last recruits 
delivered and study data collection ended.
Resource Use
Using case report forms for mothers and babies, information was col-
lected on healthcare utilization from randomization until maternal 
primary hospital discharge after birth and infant primary hospital dis-
charge home. Table 1 lists the 24 services and 11 hospital ward stays 
that were considered to assess cost.
The total maternal hospital length of stay was available, but not by 
hospital ward type, which varies substantially in cost; therefore, the 
operating room duration and labor and delivery ward duration before 
and after the actual birth time were estimated for each woman using 
the mean ward duration by parity and delivery mode observed from a 
trial of women who had an external cephalic version for breech pre-
sentation.5 Women who received magnesium sulfate before or during 
delivery had their postnatal labor and delivery ward duration estimate 
increased to 24 hours after delivery for monitoring purposes accord-
ing to Canadian guidelines. All women were assumed to have had a 
labor and delivery room duration, including those who went in to the 
operating room during which time their bed was held. Time in hospi-
tal after hospital admission (but before estimated labor and delivery 
ward admission) was ascribed to the antenatal ward, and time after 
estimated labor and delivery discharge to actual hospital discharge 
was ascribed to the postnatal ward, totaling the actual maternal hos-
pital length of stay.
Infants admitted to high-level neonatal care did not have their ac-
tual level of care indicated, given the variability in definition of in-
termediate and intensive care across hospitals. For costing purposes, 
cases of high-level neonatal care were categorized masked to treat-
ment allocation into level 3 or level 2 neonatal ward care. Level 3 
neonatal intensive care was attributed to babies with characteristics 
consistent with provincial admission guidelines and billing defini-
tions, as follows: birth at <32 weeks, birth weight <1500 g, receipt of 
any positive pressure ventilation (continuous positive airway pressure 
or endotracheal intubation), or any of ten serious neonatal morbidi-
ties (ie, patent ductus arteriosus, early-onset sepsis within the first 48 
hours of life, bronchopulmonary dysplasia, retinopathy of prematuri-
ty stage >2, intraventricular hemorrhage, cystic periventricular leuko-
malacia, hypoxic-ischemic encephalopathy, necrotizing enterocolitis, 
laparotomy, or thoracotomy). All other high-level neonatal care was 
regarded as level 2 intermediate care. Any neonatal hospital transfer 
was assumed to be for the purposes of the other type of care (ie, level 
3 transfer to level 2 and level 2 transfer to level 3).
Unit Costs for Physician Services and Wards
Physician services were costed using the provincial government 
health insurance plan schedule of medical benefits applicable to 2013 
for Ontario, British Columbia, and Alberta.6–8 Healthcare billing 
experts and clinicians in each province assisted with the identification 
and interpretation of appropriate billing codes. All services involved 
a flat fee or a time-dependent fee component, usually to a maximum 
amount, and a time of day and day of week premium (ie, for evening, 
night, and weekend calls). Accordingly, the fees for some services 
varied for each woman in the trial and were applied individually at 
the record level. An average unit cost per patient was calculated to 
generally illustrate the unit costs applied in each province (Table S1). 
Hospital ward durations were costed using unit costs by ward type 
and delivery mode determined for an economic analysis for a simi-
lar perinatal study in 2002, the TBT (Term Breech Trial),9 that were 
updated to 2013 using the Canadian Consumer Price Index healthcare 
commodity group of 20.5%.10 Ward unit costs were not province spe-
cific, but were derived in the TBT from reports from 4 teaching hos-
pitals and 3 community hospitals in each of the included provinces 
(ie, Ontario, British Columbia, and Alberta) combined into 1 median 
unit cost per ward type per hour (Table S2). Further definitions and 
assumptions for physician services and ward durations are included 
in Table S3. Table S4 summarizes the methods used to derive hospital 
ward unit costs and their application in this study.
Data Analysis
Costing involved multiplying the actual amount of resources con-
sumed by each participant as collected in the trial by their respec-
tive unit costs to determine the total cost of each of 24 services and 
each of 11 ward stays. The total cost of all 24 services, the total cost 
of all 11 wards, and the overall total cost of all services and wards 
were calculated using each province’s unit costs for less tight and 
tight BP management groups. All results were analyzed according 
to the intention-to-treat approach that included 493 women in the 
less tight group and 488 women in the tight group, and excluded 6 
women who withdrew or were lost to follow-up in CHIPS (Control 
of Hypertension in Pregnancy Study). The total per-participant costs 
for mothers and infants in each arm of the trial were not assumed 
 by guest on January 15, 2018
http://hyper.ahajournals.org/
D
ow
nloaded from
 
Ahmed et al  Control of Hypertension in Pregnancy Costs  1051
Table 1. Healthcare Resources Consumed by Study Groups in Trial
Healthcare Resource Consumed (24 Services and 11 Hospital Ward Lengths 
of Stay)
Less Tight Group Tight Group
n
Resources
n  
Women/Infants
n
Resources
n  
Women/Infants
Outpatient assessments/visits
 1. Antenatal visit—Physician service 3683 483 3787 473
 2. Antepartum home care visit—Nursing service 545 108 529 105
 3. Obstetric day unit visit—Physician service 653 181 636 181
 4. Obstetric day unit visit—Ward care 653 visits (7836 h) 181 636 visits (7632 h) 181
 5. Emergency room visit—Physician service 403 199 387 177
 6. Emergency room visit—Ward care 403 (2015 h) 199 387 (1935 h) 177
Antenatal hospitalizations not for delivery
 7.  Antenatal hospital admission not for delivery, and daily  
care—Physician service
163 131 145 121
 8. Antenatal hospital admission not for delivery, length of stay—Ward care 450 days (10 800 h) 131 460 days (11 040 h) 121
Diagnostic tests
 9. Maternal blood and urine tests—Physician laboratory service 2433 459 2306 450
 10. Nonstress tests—Physician service 1878 359 2137 355
 11. Fetal ultrasounds—Physician service 1653 458 1631 454
 12. Infant chest x-rays—Physician service 277 74 163 54
 13. Infant head ultrasound—Physician service 166 68 118 62
 14. Infant head CT scan—Physician service 2 1 3 3
 15. Infant MRI—Physician service 5 4 3 3
 16. Ophthalmology examination for ROP—Physician service 97 66 84 59
Hospital length of stay for delivery
 17. Antenatal ward 30 584.76 h 480 29 573.31 h 474
 18. Labor and delivery ward 6559.24 h 493 6171.56 h 488
 19. Operating room 335.86 h 258 375.38 h 290
 20. Postnatal ward 39 263.77 h 493 37 061.70 h 488
Delivery
 21.  Caesarean section delivery before labor—Physician service 
(obstetrician, assistant, and anesthetist)
159 159 163 163
 22.  Caesarean section delivery during labor (CS and spontaneous or 
induced)—Physician service (obstetrician, assistant, and anesthetist)
72 72 87 87
 23. Spontaneous vaginal delivery—Physician service 234 234 196 196
 24. Operative vaginal delivery—Physician service 27 27 40 40
 25. Elective termination—Physician service 1 1 1 1
 26. Miscarriage—Physician service 0 0 1 1
 27. Induction—Physician service 224 224 218 218
Neonatal care
 28. NICU level 2 at delivery hospital—Physician service 765 d 84 664 d 83
 29. NICU level 3 at delivery hospital—Physician service 2531 d 72 1680 d 68
 30. NICU level 2 at transfer hospital—Physician service 580 d 19 424 d 15
 31. NICU level 3 at transfer hospital—Physician service 134 d 6 77 d 8
Aggregated: NICU level 2 and level 3 at both delivery and transfer hospital—
Physician service (Total high-level neonatal physician service)
96 240 h (4010 d) 156 68 280 h (2845 d) 151
(Continued )
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to be normally distributed. As such, the standard errors (SEs) of the 
difference in the means between groups and 95% CIs of the differ-
ences in the means were estimated using bootstrap methods and P 
values were estimated using permutation in “R” statistical software 
version 3.2.2.11 For each province, CIs and P values were estimated 
for all services, all wards, and for all services and all wards together. 
To demonstrate which specific services or wards were cost-drivers 
between less tight and tight control, we determined the absolute dif-
ference in mean cost between study groups for each service and ward, 
ranked the cost differences in descending order of magnitude, and for 
the top 5 cost-drivers where parameters were similarly estimated, we 
tested their significance assuming no distribution and using permuta-
tion, and found their 95% CIs using boot-strapping.
Results
Primary/transfer hospital ward durations were costed to a max-
imum of 305 days after which no women or babies remained 
in hospital. Women and infants in the less tight group relative 
to the tight group consumed less of 7 services and spent less 
time on 2 wards (antenatal physician visits, nonstress tests, 
antenatal hospitalization not for delivery ward time, Caesarean 
section delivery before labor, Caesarean section delivery dur-
ing labor, operative vaginal deliveries, miscarriages, operating 
room time, and infant head CT scans), but consumed more 
of 16 services and spent more time on 9 wards (antepartum 
home care visits with a nurse, obstetric day unit visits and ward 
time, emergency room visits and ward time, antenatal hospi-
tal admissions not for delivery, maternal blood and urine tests, 
fetal ultrasounds, infant chest x-rays, infant head ultrasounds 
and MRIs, ophthalmology exams for retinopathy of prema-
turity, longer lengths of stay in the antenatal ward, labor and 
delivery ward, postnatal ward, more spontaneous vaginal 
deliveries, inductions for labor, and more physician care and 
longer length of stay in level 2 and level 3 neonatal care at 
delivery and transfer hospitals). Both groups had the same 
number of elective terminations (Table 1). Although the less 
tight (compared with the tight) group had a similar number of 
overall admissions to high-level neonatal care level 2 or 3 (156 
versus 151 neonates), the total length of stay of less tight group 
neonates was substantially longer (total of 3921.34 days versus 
2763.96 days, or 41.8% more days), especially in level 3 neo-
natal intensive care at delivery hospitals, an important differ-
ence with associated clinical implications, regardless of cost.
The mean cost in each group represents the total cost 
incurred for each service or ward consumed by women in that 
group divided by the total number of women (493 or 488) in 
the study group, whether or not they incurred the service or 
ward (Table S5). Overall, there was no significant difference 
in the mean cost of all services and wards between less tight 
and tight control groups in each province (Table 2), with simi-
lar direction and magnitude of effect. Women in the less tight 
control group incurred costs that were close to $6000 dollars 
more than women in the tight control, but the difference was 
not statistically significant.
Table S6 shows the top 5 items with the greatest difference 
in mean cost between the study groups. All were related to 
 32. NICU level 2—Delivery hospital—ward care 724.28 d 84 626.09 d 83
 33. NICU level 3—Delivery hospital—ward care 2495.32 d 72 1651.02 d 68
 34. NICU level 2—Transfer hospital—ward care 570.44 d 19 414.39 d 15
 35. NICU level 3—Transfer hospital—ward care 131.29 d 6 72.46 d 8
Aggregated: NICU level 2 and level 3 at both delivery and transfer hospital 
(Total high-level neonatal ward care)
94 112.04 h  
(3921.34 d)
156 66 334.68 h  
(2763.95 d)
151
CS indicates Caesarean section; CT, computed tomography; MRI, magnetic resonance imaging; NICU, neonatal intensive care unit; and ROP, retinopathy of prematurity.
Table 1. Continued
Healthcare Resource Consumed (24 Services and 11 Hospital Ward Lengths 
of Stay)
Less Tight Group Tight Group
n
Resources
n  
Women/Infants
n
Resources
n  
Women/Infants
Table 2. Analysis of Difference in Mean Costs of All Services and Wards, All Services, and All Wards by Study Group
Service and 
Ward Cost Province
Less Tight Group
n=493 Women/Infants
Tight Group
n=488 Women/Infants
Difference 
Between Less 
Tight and Tight 
Mean Costs*
95% Confidence 
Interval
SE (Difference 
in Means) P ValueMean SE (Mean) Mean SE (Mean)
Total cost of 
all services 
and wards
Ontario $30 191.62 $2703.18 $24 469.06 $1646.23 $5723 −$296, $12 272 $3184.89 0.0725
B.C. $30 593.69 $2756.47 $24 776.51 $1668.60 $5817 −$385, $12 349 $3227.88 0.0725
Alberta $31 510.72 $2821.73 $25 510.49 $1705.26 $6000 −$154, $12 781 $3308.47 0.0637
Total cost of 
all services
Ontario $3323.27 $137.19 $3060.41 $105.75 $263 −$62, $606 $170.74 0.1351
B.C. $3725.34 $187.12 $3367.85 $128.02 $357 −$80, $826 $230.30 0.1197
Alberta $4642.37 $255.44 $4101.83 $168.68 $541 −$42, $1170 $305.50 0.0784
Total cost of 
all wards
All Provinces $26 868.35 $2573.40 $21 408.65 $1546.70 $5460 −$202, $11 560 $3015.76 0.0694
SE indicates standard error. *Positive value favors less costly tight group.
 by guest on January 15, 2018
http://hyper.ahajournals.org/
D
ow
nloaded from
 
Ahmed et al  Control of Hypertension in Pregnancy Costs  1053
neonatal intensive care. The top 4 cost-drivers were neonatal 
care ward costs at the delivering and transfer hospitals. In the 
less tight group, high-level neonatal intensive care ward costs 
represented the majority of overall costs: at 56.8% of over-
all cost per woman/infant dyad in Ontario, 56.1% in British 
Columbia, and 54.5% in Alberta. There was no statistically 
significant difference between the study groups in any of the 
top 5 cost drivers.
Discussion
Main Findings
There has been much debate about the best approach to the 
management of hypertension.2 The CHIPS trial showed that 
tight BP control is not harmful to the baby, and consistent 
with literature from other clinical trials, was beneficial to the 
mother by decreasing the development of severe hyperten-
sion.12 To our knowledge, the analysis reported here is the 
first to compare the cost implications of less tight versus tight 
BP control strategies for pregnancy hypertension. The study 
found that the mean cost per woman–infant dyad managed 
by a policy of less tight (versus tight) BP control is not sig-
nificantly different with regard to overall services and hospital 
ward costs incurred from as early as from 14 weeks of gesta-
tion up to 305 days after delivery (ie, last neonatal primary 
hospital discharge date recorded), using costs obtained from 
Ontario, British Columbia, or Alberta, Canada.
Although costs in each province were almost $6000 
higher for the less tight group in which infants spent more 
time in high-level neonatal intensive care wards, the result did 
not reach statistical significance and may reflect a lack of sta-
tistical power.13,14
The upper and lower limits of the 95% CI can be examined 
to determine whether they would exclude a minimally impor-
tant (cost) difference (MID), like that used for noninferiority 
trials.15,16 If the MID is either outside or included within both 
CI boundaries, then neither treatment strategy is significantly 
different in cost and the decision threshold to change policy 
is not reached. However, if an MID is included on one side 
of the 95% CI boundaries but not on the other, the decision 
threshold is reached for that treatment if adopted, and would 
be associated with cost savings per patient to at least the level 
of the MID: similar savings would not be experienced if the 
alternate treatment approach was adopted. In our study, a deci-
sion maker might determine, for example, that a difference 
in mean cost per patient of ±$500 is an MID threshold above 
which a less tight or tight policy would be attractive to imple-
ment. Using outcomes for British Columbia in our study, the 
total mean cost per patient was $30 593.69 for less tight and 
$24 776.51 for tight groups, with a difference in mean costs 
of $5817, and CI of −$385 cost savings up to a $12 349 cost 
increase, for a less tight patient (Table 2). In this example, with 
an MID of $500, we could exclude a cost savings with a policy 
of less tight control. Tight control may be substantially cheaper 
with a marked reduction in neonatal intensive care unit days.
Study Strengths and Limitations
The data come from CHIPS, a large, international, multi-
center randomized trial. Resource utilization was measured 
prospectively and the economic analysis planned, all con-
tributing to minimization of bias in cost assessment between 
groups. The analysis used mean costs from 3 Canadian 
provinces with different fee structures related to provin-
cial schedules of medical benefits, especially flat rate fees, 
premiums for start time of day and day of week, and time-
dependent fees. The direction and magnitude in the differ-
ence in mean cost of overall services and wards in each of 
the 3 provinces were similar, all favoring tight control as less 
expensive. The purpose of conducting the analysis in each 
province was to demonstrate the independence of findings 
from the effect of jurisdiction and price structures, similar to 
a sensitivity analysis. Any specific cost differences between 
provinces are ultimately less important than the fact that the 
interventions were costed in 3 different healthcare jurisdic-
tions with different funding and price structures, yet pro-
duced a similar magnitude and direction in results, which 
supports the validity of the findings. There were no major 
differences between provinces, which supports the general-
izability in this context.
Our study is limited by the application of 2002 TBT 
ward unit costs scaled for health commodity inflation in 
Canada to 2013 trial data: true ward unit costs incurred by 
hospitals in each province in 2013 may be different. The 
TBT combined ward type unit cost data for each province, 
so we could not report province-specific total ward costs. 
TBT ward unit costs were derived for women with breech 
pregnancies, their infants and costs of related complica-
tions, which may underestimate these costs for hyperten-
sive pregnancies. However, hypertension-specific care was 
accounted for, such as more time allocated on the labor and 
delivery ward to women on magnesium sulfate to capture 
the enhanced nursing care required. CHIPS women may 
have had different mean lengths of stay on the labor and 
delivery ward and in the operating room for Caesareans 
than those in the EECV2 (Early External Cephalic Version 
2) trial from which costs were estimated, although these 
durations are not likely to be substantially different in the 
overall findings, and total hospital length of stay in CHIPS 
was preserved. Whereas CHIPS women may have received 
more interventions than EECV2 women, this approach is 
conservative and has been applied equally to both the study 
groups. The neonatal intensive care level 3 ward unit cost of 
$107.00/h from the TBT may be higher for CHIPS neonates 
who may require a higher intensity of hospital care, related 
to nursing staff time, hospital service consumables used, 
and associated ward costs. The time spent in any high-level 
care was preserved, but we were unable to standardize a def-
inition of levels 2 and 3 neonatal care across jurisdictions: 
categorization of high-level neonatal care into levels 2 and 
3 care cases was performed according to an algorithm that 
may not have reflected the true level, intensity and cost of 
care received. Although every attempt was made to ensure 
the correct billing codes in each province were applied to 
the physician service resources consumed in CHIPS, actual 
billing practice of individual physicians vary by individual 
practice (such as the use of after-hours codes), time of day, 
and day of week that care was provided. The trial collected 
data from 94 centers in 15 countries, with centers selected 
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to have similar facilities, conditions and medical practices 
to fulfill the CHIPS Protocol as in Canada. However, the 
resources consumed in the trial may differ from that which 
would have been consumed in the actual Canadian context, 
although any potential differences cannot be easily ascer-
tained. Nonetheless, the application of any estimates was 
applied to both groups equally. As for all clinical efficacy sce-
narios, our results apply to the 3 provinces mentioned because 
we used their unit prices. No subgroup analysis was done with 
Canadian study participants only.
The CHIPS trial, as with many randomized controlled 
trials, was powered for the primary study outcome and not 
the cost analysis, which typically requires larger sample sizes 
because of large variances and positively skewed distributions 
of cost, as observed in this analysis. It is possible that a larger 
sample size may have confirmed the observed trend toward a 
higher mean cost per woman in the less tight group, driven by 
the longer infant length of stay in high-level neonatal intensive 
care units. More than 55% of the cost of care was attributed 
to neonatal costs, which was the top cost-driver in each of the 
3 provinces, raising the possibility that differences seen in the 
primary study may be real.
Perspectives
The mean cost for women/infants under a less tight treatment 
approach to pregnancy hypertension is not different to those 
under a tight control approach. However, based on our find-
ings, there is little chance that less tight control is cheaper; 
and in the main CHIPS Study, less tight control was impli-
cated in significantly more morbidity among women. Thus, a 
treatment approach of tight control of pregnancy hypertension 
may have clinical benefit for women, with no increased risk to 
neonates and without additional (and possibly lower) cost to 
the healthcare system.
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What Is New?
•	This study presents a cost analysis of less tight versus tight blood pres-
sure management strategies for women with chronic or gestational hy-
pertension in a large, multicenter randomized controlled trial.
What Is Relevant?
•	The CHIPS trial (Control of Hypertension in Pregnancy Study) found no 
difference in pregnancy loss or high-level neonatal care >48 hours when 
comparing a less tight (target 100 mm Hg) and tight (target 85 mm Hg) 
approach to blood pressure management during pregnancy. However, 
women in the CHIPS study experienced significantly less morbidity with 
a tight approach.
•	No significant difference was found in mean total cost of all services and 
wards per woman–infant dyad between less tight versus tight strategies.
Summary
Tight blood pressure control in pregnancy may benefit women 
without increasing risk to neonates (as shown in the main CHIPS 
trial), without additional (and possibly lower) cost to the healthcare 
system.
Novelty and Significance
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Medical University of South Carolina, Charleston (11):  Eugene Y. Chang, Tamara D. Saunders, 
Betty W. Oswald, Kristin D. Zaks  
Beth Israel Deaconess, Boston (8):  Sarosh Rana, Dawn McCullough 
Yale-New Haven Hospital, New Haven (8):  Anna Sfakianaki, Cheryl Danton, Erin Kustan, 
Luisa Coraluzzi 
Norton Hospital Downtown (7), Norton Suburban Hospital (2), Louisville:  Helen How, 
Christina Waldon 
East Carolina University, Greenville (6):  Jeffrey Livingston, Sherry Jackson, Lisa Greene 
Meriter Hospital, Madison (6):  Dinesh Shah  
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Oregon Health & Science University, Portland (5):  Jorge E. Tolosa, Monica Rincon, Leonardo 
Pereira, Amy E.  Lawrence, Janice E.  Snyder 
University of North Carolina, Chapel Hill (4):  D. Michael Armstrong, Teresa Blue, Austin 
Hester, Kathryn Salisbury 
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S1. Average or general unit cost of 24 services per woman/infant by province and study group  
 
Service Province 
  
‘Less tight’ Group ‘Tight’ Group 
Average SD Average SD 
Assessments/Visits           
1. Antenatal visit - Physician service Ontario $256.97 $150.88 $269.81 $159.48 
B.C. $229.90 $134.98 $241.39 $142.68 
Alberta $268.87 $157.86 $282.30 $166.87 
2. Antepartum home care visit - Nursing service Ontario $583.81 $467.70 $582.86 $470.74 
B.C. $691.04 $553.61 $689.92 $557.20 
Alberta $700.58 $561.25 $699.44 $564.89 
3. Obstetrical Day Unit visit - Physician service Ontario $269.50 $232.06 $262.48 $207.97 
B.C. $166.75 $143.59 $162.41 $128.68 
Alberta $181.29 $156.11 $176.57 $139.90 
4. Emergency room visit - Physician service Ontario $75.33 $80.05 $81.34 $77.75 
B.C. $143.22 $152.18 $154.63 $147.81 
Alberta $193.56 $205.68 $208.98 $199.77 
 
Antenatal Hospitalization Not For Delivery 
          
5. Antenatal hospital admission not for delivery and daily visits  
    - Physician service 
Ontario $167.33 $113.91 $176.45 $131.34 
B.C. $168.19 $114.77 $177.43 $132.32 
Alberta $164.06 $118.14 $174.68 $135.97 
 
Diagnostic Tests 
          
6. Maternal blood and urine tests - Physician laboratory service Ontario $235.18 $188.97 $226.33 $172.56 
B.C. $272.80 $218.34 $262.52 $199.20 
Alberta $556.43 $467.84 $535.78 $430.75 
7. Non-stress tests - Physician service Ontario $50.48 $58.01 $58.09 $71.60 
B.C. $81.61 $93.78 $93.91 $115.74 
Alberta $72.14 $82.90 $83.01 $102.31 
8. Fetal ultrasounds - Physician service Ontario $295.77 $219.52 $294.41 $210.46 
B.C. $381.13 $282.87 $379.37 $271.19 
Alberta $586.47 $498.01 $583.37 $477.46 
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Service Province 
  
‘Less tight’ Group ‘Tight’ Group 
Average SD Average SD 
9.  Chest X-rays - Physician service Ontario $79.73 $143.30 $64.29 $88.69 
B.C. $125.89 $226.25 $101.51 $140.04 
Alberta $105.15 $188.98 $84.79 $116.97 
10.  Infant head ultrasound - Physician service Ontario $187.60 $147.49 $146.26 $103.86 
B.C. $246.49 $193.77 $192.17 $136.46 
Alberta $370.79 $291.50 $289.08 $205.28 
11.  Infant head CT scan - Physician service Ontario $86.50 - $43.25 $0.00 
B.C. $88.62 - $44.31 $0.00 
Alberta $131.34  - $65.67 $0.00 
12.  Infant MRI - Physician service Ontario $183.44 $73.38 $146.75 $0.00 
B.C. $221.25 $88.50 $177.00 $0.00 
Alberta $239.39 $95.76 $191.51 $0.00 
13.  Ophthalmology exam - Physician service Ontario $176.36 $136.77 $170.85 $128.40 
B.C. $134.49 $104.30 $130.29 $97.92 
Alberta $173.85 $134.82 $168.41 $126.57 
 
Delivery 
          
14. Caesarean section delivery before labor - Physician service 
      (obstetrician, assistant, anesthetist) 
Ontario $1,178.62 $271.81 $1,207.93 $271.62 
B.C. $1,008.42 $228.32 $1,024.20 $230.04 
Alberta $1,106.27 $114.99 $1,115.89 $114.82 
15. Caesarean section delivery during labor (spontaneous or  
      induced) - Physician service (obstetrician, assistant, anesthetist) 
Ontario $1,339.50 $271.12 $1,297.69 $283.63 
B.C. $1,237.66 $258.34 $1,240.92 $265.52 
Alberta $1,364.05 141.40 $1,339.62 $139.37 
16. Spontaneous vaginal delivery - Physician service Ontario $724.07 $144.35 $716.88 $143.06 
B.C. $610.11 $33.77 $609.38 $33.47 
Alberta $495.03 $46.71 $490.15 $45.31 
17. Operative vaginal delivery - Physician service Ontario $808.36 $131.20 $783.32 $156.24 
B.C. $807.41 $32.16 $809.74 $31.27 
Alberta $645.03 $41.70 $641.42 $46.42 
18. Elective termination - Physician service Ontario $804.81 - $804.81 - 
B.C. $899.08 - $899.08 - 
Alberta $941.73 - $941.73 - 
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Service Province 
  
‘Less tight’ Group ‘Tight’ Group 
Average SD Average SD 
19. Miscarriage - Physician service Ontario - - $1,107.76 - 
B.C. - - $665.22 - 
Alberta - - $747.12 - 
20. Induction - Physician service Ontario $126.35 $0.00 $126.35 $0.00 
B.C. $258.82 $12.91 $259.56 $16.22 
Alberta $240.42 $0.00 $240.42 $0.00 
 
Neonatal care 
          
21. NICU level 2 at delivery hospital - Physician service Ontario $1,241.21 $1,171.83 $1,105.25 $811.62 
B.C. $1,637.17 $1,274.50 $1,511.21 $918.67 
Alberta $2,118.32 $2,219.60 $1,860.80 $1,537.32 
22. NICU level 3 at delivery hospital - Physician service Ontario $5,203.49 $4,404.27 $4,020.72 $2,824.94 
B.C. $6,822.58 $7,039.61 $5,054.63 $3,636.66 
Alberta $8,176.54 $9,955.46 $5,746.59 $4,966.99 
23. NICU level 2 at transfer hospital - Physician service Ontario $3,748.63 $2,014.64 $3,471.15 $2,414.18 
B.C. $4,105.00 $1,998.83 $3,812.37 $2,414.62 
Alberta $7,100.42 $3,816.00 $6,574.83 $4,572.80 
24. NICU level 3 at transfer hospital - Physician service Ontario $3,086.13 $3,887.51 $1,722.39 $662.27 
B.C. $4,262.47 $5,660.83 $2,249.82 $727.10 
Alberta $5,194.73 $7,905.21 $2,238.77 $860.82 
Aggregate: NICU level 2 and level 3 at both delivery and transfer 
                   hospital - Physician service (Total “high level” neonatal  
                   physician service) 
Ontario $3,645.21 $4,013.55 $2,854.24 $2,812.76 
B.C. $4,694.35 $5,793.23 $3,604.83 $3,444.36 
Alberta $5,979.01 $8,091.79 $4,382.43 $4,743.68 
SD (standard deviation) 
NICU (neonatal intensive care unit) 
Note: Average unit costs were calculated using the total cost divided by the number of women or infants that actually incurred that 
service to illustrate a general form of unit cost; whereas actual fees varied for each study participant depending on the number of 
services received for each woman/infant, the duration of the service or the time of day and week fee premiums applicable according to 
each province’s Schedule of Medical Benefits. 
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S2. Unit cost per hour for 11 hospital wards 
 
Hospital Ward Delivery Mode 
Unit Cost Per Hour8,9 
CAN$2013 
Antenatal ward (pre-labor Caesarean delivery unit cost used for emergency 
room ward; all other modes unit cost used for: obstetrical day unit, antenatal 
hospital admission not for delivery, and antenatal ward for delivery) 
Pre-labor Caesarean delivery $31.86 
All other modes $30.98 
Labor and delivery ward Caesarean delivery $281.17 
Vaginal delivery $213.49 
Operating room All modes $989.75 
Postnatal ward Caesarean delivery $31.86 
Vaginal delivery $30.98 
Intermediate nursery care unit level 2 at delivery or transfer hospital All modes $55.14 
Neonatal intensive care unit level 3 at delivery or transfer hospital All modes $107.00 
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S3. Definitions and Assumptions for Physician Services and Ward Durations 
 
In general, no fee premiums were applied for special physician visits (e.g. no sacrifice of office 
hours or travel to attend to a case) or special patient fee modifiers (e.g. high maternal BMI, 
preterm delivery). No initial complex patient bonus or initial assessment fee was applied to 
antenatal physician visits (minor) as the first visit occurred prior to randomization. Antepartum 
home care visits assumed one hour total return travel and one hour home visit by one senior 
obstetrical nurse with commensurate wages, benefits, pension, travel premium, responsibility 
premium and car depreciation fee where applicable according to provincial or hospital collective 
agreements. Obstetrical day unit physician visits assumed one physician high risk prenatal 
visit/complex obstetrical patient (20 minute) with no interventions, procedures, delivery or 
hospital admission, time of day or week premiums, travel or sacrifice of office hours during 
regular office hours; cost of any physician interpretation of non-stress test was included under 
NST cost. Each obstetrical day unit visit ward cost assumed 12 hours at pre-labor Caesarean 
section antenatal ward unit cost per hour that included nursing and hospital overhead costs. 
Emergency room visits were assumed to be during weekdays 9am-5pm with an emergency 
family physician on fee-for-service basis (not salaried, no sessional fees) for a moderate 
complexity case that included comprehensive visit, detailed history, prolonged observation, 
continuous therapy and multiple reassessments, and no premiums for time of day, day of week or 
holiday, travel, calls, first/additional person(s) seen, special visits, consultations, major 
intervention/invasive procedures, investigative ultrasounds, transfers, re-assessment, admission 
or follow-up while waiting in emergency room for further evaluation, bed or transfer. Emergency 
room visit ward cost assumed pre-labor Caesarean section antenatal ward unit cost and 5 hours 
length of stay for each visit. Antenatal hospital admission not for delivery physician cost 
included physician fee for hospital admission assessment on first day admitted for each 
hospitalization, plus physician fee for hospital visit on each subsequent day while in hospital, 
plus discharge assessment fee which is same as hospital visit fee; any admissions prior to 
randomization and any admissions missing either admission and/or discharge dates were 
excluded; assumed hospital admission during weekday regular hours (no premium), no callback 
or sacrifice of office hours premiums; admission not via emergency room. Antenatal hospital 
admission not for delivery excluded any length of stay prior to randomization and any stay 
missing admission and/or discharge date and assumed antenatal ward unit cost for deliveries 
other than pre-labor Caesarean section; assumed 0000h admission and 2359h discharge times 
where 1 day equal to 24 hours; inpatients recruited in hospital were included, but not their length 
of stay before randomization. Only the total number and not type of blood/urine tests was 
collected per patient. Laboratory costs assumed all blood/urine tests were recorded were on an 
outpatient basis. If woman was <=21 weeks gestational age at randomization, then first 
blood/urine test included: specimen collection fee, Triple Marker Screening (TMS: alpha-
fetoprotein AFP, human chorionic gonadotropin hCG and unconjugated estriol uE3), Glucose 
Challenge Test for gestational diabetes (GCT) and complete blood count (CBC). If gestational 
age >21 weeks and <=24 weeks at randomization, then first blood/urine test included: specimen 
collection fee, GCT and CBC (no TMS, since before randomization); any remaining blood/urine 
tests were assumed to be for pre-eclamptic toxemia (PET) panel: specimen collection fee, CBC, 
urea/BUN, creatinine, AST, ALT, LDH, bilirubin, uric acid, and mean cost of 4 different 
common proteinuria tests: urinary dipstick for creatinine or proteins, protein:creatinine ratio, 24 
hour urine collection for creatinine or proteins and albumin:creatinine ratio; no laboratory ward 
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cost was included. Non-stress test included physician interpretation; any ward cost was 
considered elsewhere, e.g. in ODU, ER, hospitalization not for delivery, antenatal ward for 
delivery, etc. Fetal ultrasound physician cost assumed private out-of-hospital clinic associated 
with hospital, no ward cost, and included physician interpretation fee and technician fee if 
applicable, with physician on-site to supervise ultrasound technician and interpret ultrasound; all 
ultrasounds were complete and not partial; first ultrasound was assumed for pregnancy and 
subsequent ultrasound(s) for high risk assessment. Infant chest x-ray and infant head ultrasound 
unit costs included physician interpretation and technician fees where applicable and assumed in-
hospital ward cost was already included in level 2 or level 3 neonatal care ward cost. Infant head 
CT scan and infant head MRI unit costs included physician interpretation fee, and assumed 
technician fee and in-hospital ward cost already included in level 2 or level 3 neonatal care ward 
cost. Retinopathy of prematurity unit costs included physician consultation/assessment fees and 
assumed ward fee already included in level 2 or level 3 neonatal care unit or postnatal ward. 
CHIPS total actual maternal hospital length of stay from admission to maternal hospital 
discharge home was divided in antenatal, labor and delivery, operating room and postnatal ward 
durations, based on EECV2 trial mean length of stay (excluding breech births) in the labor and 
delivery ward and operating room for Caesarean section, by parity and delivery mode, where 
remaining time between actual hospital admission and calculated labor and delivery ward 
admission time was assigned as antenatal ward length of stay, and remaining time from 
calculated labor and delivery ward discharge to actual hospital discharge was assigned as 
postnatal ward length of stay for each study participant. Operating room time was embedded 
within labor and delivery ward duration where the bed was kept. The sum of all estimated ward 
lengths of stay was equal to the total actual CHIPS hospital length of stay for each patient. Some 
patients were randomized as inpatients whose length of stay prior to labor and delivery was 
included in the antenatal ward duration. Inpatients may contribute more antenatal ward time per 
patient than expected for a typical delivery, and was assumed to be balanced between study 
groups due to randomization. Women who received magnesium sulfate anytime before or during 
delivery had an additional 24 hours for monitoring added to their existing labor and delivery unit 
ward duration and 24 hours reduced from their postpartum ward duration. Caesarean section 
before labor or during labor (CS and spontaneous or induced) physician fee assumed one 
obstetrician, one surgical assistant and one anesthetist with time of day and week premiums for 
operating room modelled around actual birth time and operating room duration modelled based 
on EECV2 trial mean ward duration by delivery mode and parity. No procedural fee modifiers 
(i.e. patient complexity fee) were used. The majority of service provided was assumed to be 
within initial start time of day and week period, where all physicians worked on one case only, 
with no sacrifice of office hours, no travel premiums; uncomplicated patient and fetus, Ontario 
(or equivalent) ASA level 1 (uncomplicated patient for anesthesia); anesthetist cost is the same 
regardless of approach (epidural, spinal or general anesthesia); no surgeon or anesthetist pre-
surgery patient assessment time cost; no post-operative anesthetic monitoring fee or post-
operative pain management cost (monitoring); anesthetist time was assumed to be only during 
operating room; no surgeon follow-up visit. Spontaneous vaginal and operative vaginal delivery 
physician fees assumed one obstetrician only, cephalic presentation, no second assistant 
obstetrician, no anesthetist and no episiotomy or repair of tear; for operative delivery, assumed 
mid-cavity extraction, vacuum or forceps. Elective terminations of pregnancy were assumed to 
involve dilatation and evacuation, miscarriages were assumed to involve dilation and curettage, 
and both procedures assumed one obstetrician and one anesthetist for 30 minutes operating room 
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time.  Induction assumed only one oxytocin-type induction during day time on a weekday, and 
only one hour of oxytocin infusion billable to physician, although infusion may have been 
longer. Assessment of a normal newborn was included in the physician delivery fee. 
Neonatologist consultation fees for admission to a level 2 neonatal intermediate care unit or level 
3 neonatal intensive care unit were included in the first day level 2 or level 3 physician fee per 
diem. Level 2 neonatal intermediate care ward included monitoring (invasive or non-invasive), 
oxygen administration and intravenous therapy or parenteral alimentation but without ventilatory 
support. Level 3 neonatal intensive care ward included full life support, full intensive monitoring 
(either invasive or non-invasive), artificial ventilation, parenteral alimentation (all modalities) if 
necessary, and all procedures. Ontario and British Columbia fee schedules considered 
neonatologist per diems for level 2 and level 3 neonatal care. An Alberta neonatologist per diem 
was derived from the "Neonatal Intensive Care Unit (NICU) Calgary Clinical Alternative 
Relationship Plan (ARP)" [Government of Alberta Ministerial Order M.O. 124/2103, dated 
March 28, 2013, amending M.O. 124/2013] contract for neonatologists serving 102 NICU level 
2 and level 3 beds at: Foothills Medical Centre NICU (levels 2 and 3, total 39 beds), Peter 
Lougheed Centre (NICU levels 2 and 3, total 30 beds) and Rockyview General Hospital (NICU 
levels 2 and 3, total 33 beds) out of a total of 251 NICU levels 2 and 3 beds in Alberta overall 
(87 NICU level 3 beds and 164 NICU level 2 beds with an overall occupancy rate of 90% in 
2013, according to personal communication with Jeremy Anthony, Manager, Program Design 
and Delivery, Workforce Design Branch, Alberta Health on February 19, 2015), towards 
calculating a per diem based on 41% of neonatal care beds in Alberta. The 2013 ARP stipulates a 
maximum annual compensation of $7,799,237.32 (total NICU neonatologist budget) from April 
1, 2013 to March 31, 2014 for a maximum of 15.55 Full Time Equivalent neonatologists 
($501,558.67 annual payment rate per FTE) serving a total of 102 NICU level 2 and level 3 beds 
at these 3 hospitals. Assuming 102 NICU beds for 365.25 days/year for maximum 37,255.5 bed 
days/year at 90% occupancy, the estimated total number of actual NICU beds is 33,529.95 bed 
days/year. The Alberta NICU level 2 and level 3 neonatologist per diem was calculated by 
dividing the total NICU neonatologist budget of $7,799,237.32 by the total number of NICU bed 
days of 33,529.95 days/year for a per diem of $232.60 per neonate per day for either level 2 or 
level 3 neonatal care. Length of stay in a level 2 or level 3 neonatal care ward was calculated to 
the hour for ward costs, and was rounded up to the nearest integer day for neonatologist per 
diem.  
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S4. Methods used to derive hospital ward unit costs in the Term Breech Trial and their 
application in the CHIPS trial 
 
The CHIPS trial study used hospital ward unit costs as determined for 2002 in the Term Breech 
Trial (TBT) and adjusted to 2013 using the Canadian Consumer Price Index (CPI) health care 
commodity group. In summary: [9] TBT ward unit costs were calculated using financial and 
statistical reports on ICD codes and case mix groups provided by 4 teaching hospitals and 3 
community hospitals in each of Ontario, British Columbia and Alberta.  A group of women and 
infants similar to those in the TBT was selected in each of the 7 hospitals for whom all direct and 
indirect (i.e. overhead) costs were provided related to their length of hospital stay, the duration of 
stay in each hospital ward and the costs of different services allocated to these wards. The total 
unit cost per hour for each hospital ward was determined by adding the per-hour costs of all of 
the services that occurred in that ward. The median unit cost between the high and low unit cost 
estimates across the 7 hospitals was used. TBT ward unit costs were scaled from 2002 by 20.5% 
to 2013 Canadian dollars, the year when recruitment ended in the CHIPS trial, using the 
Canadian Consumer Price Index (CPI) for health care commodities. In the CHIPS trial, 2013 
adjusted TBT antenatal ward unit cost for vaginal delivery was applied to: obstetrical day unit, 
antenatal hospital stay not for delivery ward and antenatal ward for vaginal delivery; the slightly 
higher TBT antenatal ward unit cost for pre-labor Caesarean delivery was applied to emergency 
room ward to reflect a greater intensity of care. The TBT labor and delivery ward and postnatal 
ward unit costs were applied accordingly in the CHIPS trial by Caesarean or vaginal delivery 
modes. The TBT operating room, intermediate nursery care unit and neonatal intensive care unit 
ward unit costs were applied accordingly in the CHIPS trial. Only “high level” neonatal care was 
collected in the CHIPS trial. For the purpose of physician and ward costing, CHIPS neonates in 
"high level" neonatal care were categorized into NICU level 2 or level 3 care using an algorithm 
based on severity of illness: Level 3 NICU=Gestational age (GA) <32 weeks or any Positive 
Pressure Ventilation (PPV; within first 72 hours of life beyond the initial resuscitation period via 
Endotracheal Intubation, EI, or Continuous Positive Airway Pressure, CPAP) or 
birthweight<1500g or any of 10 serious morbidities (cases may overlap with previous criteria: 
patent ductus arteriosus, early-onset sepsis within first 48hr of life, bronchopulmonary dysplasia, 
retinopathy of prematurity stage >2, intraventricular hemorrhage, cystic periventricular 
leukomalacia, hypoxic-ischemic encephalopathy, necrotizing enterocolitis, laparotomies or 
thoracotomies). All other "high level" care cases were considered in level 2. It was assumed that 
hospital transfer was necessary either for the purpose of greater or lesser care and no other 
purpose (e.g. family convenience); if care began in level 3 care, transfer was to level 2, and if 
care began in level 2, transfer was to level 3, i.e. level 3 neonates were “stepped down” and level 
2 neonates needed higher intensity care following initial care are were “stepped up”. These 
criteria use a maximum of the case report form data for its intended purpose and are the most 
sensitive set of criteria as they include cases that would be most appropriate in level 3 care. 
GA<32 weeks is congruent with Ontario and B.C. level 3 admission guidelines. Any PPV (that 
uses CPAP or EI) discriminates between level 3 and level 2 medical benefits in Ontario and B.C. 
BW<1500g cases are most often sent to level 3 and also agree with both Ontario and B.C. 
provincial guidelines. The 10 serious morbidities are cases severe enough for level 3 admission. 
Costing included costs up to the time of discharge for mother and for baby following birth. This 
excluded the costs of any maternal or neonatal re-admission, but the data to inform costs beyond 
discharge are very limited, and introduce considerable room for error. The timeframe included is 
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a commonly used timeframe and is justified. Physician hours are rounded up to the nearest whole 
day for per diem fees; ward hours remain as actual for costing. 
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S5. Mean costs of healthcare resources by province and study group 
 
 
Service or Ward Province ‘Less tight’ Group 
N=493women/infants 
‘Tight’ Group 
N=488 women/infants 
Difference 
Between ‘Less 
tight’ and 
‘Tight’ Mean 
Costs1 
Rank of Cost Driver2 
Mean SD Mean SD Ontario B.C. Alberta 
Outpatient Assessments/Visits          
1. Antenatal visit - Physician cost Ontario $251.76 $153.67 $261.52 $163.78 -$9.76 18     
B.C. $225.24 $137.49 $233.97 $146.53 -$8.73   21   
Alberta $263.41 $160.79 $273.63 $171.37 -$10.22     20 
2. Antepartum home care visits  
    - Nursing visit cost 
Ontario $127.89 $325.58 $125.41 $323.74 $2.48 26     
B.C. $151.38 $385.38 $148.45 $383.20 $2.93   25   
Alberta $153.47 $390.70 $150.49 $388.49 $2.98     25 
3. Obstetrical Day Unit visit  
    - Physician cost 
Ontario $98.94 $191.34 $97.35 $179.15 $1.59 28     
B.C. $61.22 $118.39 $60.24 $110.85 $0.98   31   
Alberta $66.56 $128.71 $65.49 $120.51 $1.07     31 
4. Obstetrical Day Unit visit  
   - Ward cost 
All 
provinces 
$492.41 $952.25 $484.51 $891.59 $7.90 20 22 21 
5. Emergency room visit  
   - Physician cost  
Ontario $30.41 $62.83 $29.50 $60.97 $0.91 30     
B.C. $57.81 $119.45 $56.08 $115.90 $1.73   27   
Alberta $78.13 $161.44 $75.80 $156.65 $2.33     27 
6. Emergency room visit  
    - Ward cost 
All 
provinces 
$130.22 $269.06 $126.33 $261.08 $3.89 24 24 24 
 
Antenatal Hospitalizations Not 
For Delivery 
                  
7. Antenatal hospital admission 
    not for delivery and daily care  
    - Physician cost 
Ontario $44.46 $94.36 $43.75 $100.34 $0.71 32     
B.C. $44.69 $94.93 $43.99 $100.98 $0.70   33   
Alberta $43.59 $94.60 $43.31 $101.28 $0.28     33 
8. Antenatal hospital admissions 
    not for delivery - length of stay  
    - Ward cost 
All 
provinces 
$678.67 $1,641.90 $700.86 $1,790.57 -$22.19 15 13 16 
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Service or Ward Province ‘Less tight’ Group 
N=493women/infants 
‘Tight’ Group 
N=488 women/infants 
Difference 
Between ‘Less 
tight’ and 
‘Tight’ Mean 
Costs1 
Rank of Cost Driver2 
Mean SD Mean SD Ontario B.C. Alberta 
Maternal, Fetal, and Infant 
Diagnostic Tests 
                  
9. Maternal blood and urine tests  
   - Physician laboratory cost 
Ontario $218.96 $191.83 208.71 176.46 $10.25 17     
B.C. $253.98 $221.73 242.07 203.82 $11.91   18   
Alberta $518.05 $472.94 494.06 437.86 $23.99     15 
10. Non-stress tests  
      - Physician cost 
Ontario $36.76 $54.35 $42.26 $66.31 -$5.50 22     
B.C. $59.43 $87.87 $68.31 $107.19 -$8.88   20   
Alberta $52.53 $77.67 $60.39 $94.75 -$7.86     22 
11. Fetal ultrasounds  
      - Physician cost 
Ontario $274.77 $224.81 $273.89 $216.40 $0.88 31     
B.C. $354.07 $289.69 $352.94 $278.85 $1.13   30   
Alberta $544.83 $503.10 $542.73 $483.90 $2.10     28 
12. Chest X-rays - Physician cost Ontario $11.97 $62.12 $7.11 $35.55 $4.86 23     
B.C. $18.90 $98.09 $11.23 $56.13 $7.67   23   
Alberta $15.78 $81.93 $9.38 $46.88 $6.40     23 
13. Infant head ultrasound  
     - Physician cost 
Ontario $25.88 $84.59 $18.58 $61.06 $7.30 21     
B.C. $34.00 $111.14 $24.41 $80.23 $9.59   19   
Alberta $51.14 $167.19 $36.73 $120.69 $14.41     19 
14. Infant head CT scan  
      - Physician cost 
Ontario $0.18 $3.90 $0.27 $3.38 -$0.09 34     
B.C. $0.18 $3.99 $0.27 $3.47 -$0.09   34   
Alberta $0.27 $5.92 $0.40 $5.14 -$0.13     34 
15. Infant MRI - Physician cost Ontario $1.49 $17.44 $0.90 $11.48 $0.59 33     
B.C. $1.80 $21.04 $1.09 $13.85 $0.71   32   
Alberta $1.94 $22.76 $1.18 $14.98 $0.76     32 
16. Ophthalmology exam  
      - Physician cost 
Ontario $23.61 $78.01 $20.66 $71.22 $2.95 25     
B.C. $18.01 $59.49 $15.75 $54.31 $2.26   26   
Alberta $23.27 $76.90 $20.36 $70.20 $2.91     26 
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Service or Ward Province ‘Less tight’ Group 
N=493women/infants 
‘Tight’ Group 
N=488 women/infants 
Difference 
Between ‘Less 
tight’ and 
‘Tight’ Mean 
Costs1 
Rank of Cost Driver2 
Mean SD Mean SD Ontario B.C. Alberta 
Hospital Length of Stay For 
Delivery 
17. Antenatal ward cost All 
provinces 
$1,947.60 $3,409.93 $1,897.82 $3,767.42 $49.78 10 9 10 
18. Labor and delivery ward cost All 
provinces 
$3,279.45 $2,438.95 $3,152.22 $2,339.13 $127.23 6 6 6 
19. Operating room ward cost All 
provinces 
$674.27 $651.04 $761.34 $639.13 -$87.07 8 8 8 
20. Postnatal ward cost All 
provinces 
$2,508.48 $1,952.02 $2,394.59 $1,468.31 $113.89 7 7 7 
 
Delivery 
                  
21. Caesarean section before 
      labor - Physician cost 
Ontario $380.12 $572.60 $403.47 $591.42 -$23.35 14     
B.C. $325.23 $489.27 $342.10 $501.43 -$16.87   16   
Alberta $356.79 $521.73 $372.73 $530.99 -$15.94     18 
22. Caesarean section during 
       labor - Physician cost 
Ontario $195.63 $484.60 $231.35 $511.28 -$35.72 12     
B.C. $180.75 $448.40 $221.23 $488.36 -$40.48   12   
Alberta $199.21 $485.19 $238.83 $516.59 -$39.62     12 
23. Spontaneous vaginal  
      - Physician cost 
Ontario $343.68 $375.32 $287.93 $363.26 $55.75 9     
B.C. $289.59 $305.86 $244.75 $299.79 $44.84   10   
Alberta $234.96 $249.53 $196.86 $242.23 $38.10     13 
24. Operative vaginal  
      - Physician cost 
Ontario $44.27 $186.56 $64.21 $219.59 -$19.94 16     
B.C. $44.22 $184.04 $66.37 $222.53 -$22.15   14   
Alberta $35.33 $147.22 $52.58 $176.62 -$17.25     17 
25. Elective termination  
      - Physician cost 
Ontario $1.63 $36.25 $1.65 $36.43 -$0.02 35     
B.C. $1.82 $40.49 $1.84 $40.70 -$0.02   35   
Alberta $1.91 $42.41 $1.93 $42.63 -$0.02     35 
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Service or Ward Province ‘Less tight’ Group 
N=493women/infants 
‘Tight’ Group 
N=488 women/infants 
Difference 
Between ‘Less 
tight’ and 
‘Tight’ Mean 
Costs1 
Rank of Cost Driver2 
Mean SD Mean SD Ontario B.C. Alberta 
26. Miscarriage - Physician cost Ontario $0.00 $0.00 $2.27 $50.15 -$2.27 27     
B.C. $0.00 $0.00 $1.36 $30.11 -$1.36   29   
Alberta $0.00 $0.00 $1.53 $33.82 -$1.53     30 
27. Induction - Physician cost Ontario $57.41 $62.98 $56.44 $62.88 $0.97 29     
B.C. $117.60 $129.29 $115.95 $129.63 $1.65   28   
Alberta $109.24 $119.83 $107.40 $119.65 $1.84     29 
Neonatal care                   
28. NICU level 2 at delivery  
      hospital - Physician cost 
Ontario $211.48 $670.72 $187.98 $532.64 $23.50 13     
B.C. $278.95 $808.50 $257.03 $682.00 $21.92   15   
Alberta $360.93 $1,211.08 $316.49 $942.18 $44.44     11 
29. NICU level 3 at delivery 
      hospital - Physician cost 
Ontario  $759.94  $2,486.55  $560.26 $1,743.75 $199.68 5     
B.C. $996.40  $3,601.17  $704.33 $2,211.30 $292.07   4   
Alberta $1,194.14  $4,759.99  $800.75 $2,713.43 $393.39     3 
30. NICU level 2 at transfer  
      Hospital - Physician cost 
Ontario $144.47 $818.69 $106.70 $726.12 $37.77 11     
B.C. $158.20 $878.55 $117.18 $775.57 $41.02   11   
Alberta $273.65 $1,550.70 $202.10 $1,375.38 $71.55     9 
31. NICU level 3 at transfer  
      hospital - Physician cost 
Ontario $37.56 $518.00 $28.24 $232.89 $9.32 19     
B.C. $51.88 $737.92 $36.88 $298.97 $15.00   17   
Alberta $63.22 $979.88 $36.70 $302.71 $26.52     14 
Aggregated: NICU level 2 and 3  
at both delivery and transfer 
hospital - Physician cost (Total 
“high level” service cost) 
Ontario $1,153.46 $2,820.43 $883.18 $2,044.80 $270.28 - - - 
B.C. $1,485.43 $3,917.85 $1,115.43 $2,537.04 $370.00 - - - 
Alberta $1,891.94 $5,326.93 $1,356.04 $3,323.14 $535.90 - - - 
32. NICU level 2 - Delivery  
       hospital - Ward cost 
All 
provinces 
$1,944.18 $6,749.05 $1,697.83 $5,194.38 $246.35 4 5 5 
33. NICU level 3 - Delivery  
       hospital - Ward cost 
All 
provinces 
$12,997.94 $52,274.70 $8,688.14 $29,682.07 $4,309.80 1 1 1 
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Service or Ward Province ‘Less tight’ Group 
N=493women/infants 
‘Tight’ Group 
N=488 women/infants 
Difference 
Between ‘Less 
tight’ and 
‘Tight’ Mean 
Costs1 
Rank of Cost Driver2 
Mean SD Mean SD Ontario B.C. Alberta 
34. NICU level 2 - Transfer  
      hospital - Ward cost 
All 
provinces 
$1,531.24 $8,714.01 $1,123.73 $7,714.98 $407.51 2 2 2 
35. NICU level 3 – Transfer 
      hospital - Ward cost 
All 
provinces 
$683.88 $10,736.19 $381.29 $3,162.56 $302.59 3 3 4 
Aggregated: NICU level 2 and 3  
at both delivery and transfer 
hospital- Ward cost (Total “high 
level” ward cost) 
All 
provinces 
$17,157.25 $54,956.36 $11,890.99 $32,045.34 $5,266.26 - - - 
 
Notes: The mean cost here represents the total cost incurred for each service or ward divided by the total number of women in each study group (493 
or 488), whether or not they incurred the service or ward (intention-to-treat principle), yielding a mean cost per study group.  
1. The difference between mean costs per group determines which group is more costly: a positive value favors the less costly ‘tight’ study 
group.  
2. The absolute difference between ‘less tight’ and ‘tight’ group mean costs was ranked from 1=highest to 35=lowest cost difference, to 
determine which costs contribute the most difference between study groups, where 1=highest cost driver.  
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S6. Analysis of top five cost drivers  
   
Service or Ward 
Cost 
Province ‘Less tight’ Group 
N=493 women/infants 
‘Tight’ Group 
N=488 women/infants 
Difference 
Between 
‘Less tight’ 
and ‘Tight’ 
Mean Costs1 
95% 
Confidence 
Interval 
SE(Diffe
rence in 
Means) 
P-
Value 
Rank of Cost Driver 
Mean SE(Mean) Mean SE(Mean) Ontario B.C. Alberta 
33. NICU level 3 
- Delivery   
          hospital                   
- Ward cost 
All 
$12,997.94 $2,354.33 $8,688.14 $1343.64 $4,310 -$804, $9,987   $2,741 0.112 1 1 1 
34. NICU level 2 
- Transfer  
          hospital          
- Ward cost 
All 
$1,531.24 $392.46 $1,123.73 $349.24 $408 -$624, $1,436  $520 0.446 2 2 2 
35. NICU level 3 
- Transfer  
          hospital           
- Ward cost 
All 
$683.88 $483.53 $381.29 $143.16 $303 -$439, $1,450  $501 0.824 3 3 4 
32. NICU level 2 
- Delivery  
          hospital                 
- Ward cost 
All 
$1,944.18 $303.96 $1,697.83 $235.14 $246 -$510, $1,017  $388 0.525 4 5 5 
29. NICU level 3 
- Delivery  
          hospital                          
- Physician 
          cost 
Ontario  $759.94  $111.99 $560.26 $78.94 $200 -$65, $466 $135 0.142 5     
B.C. $996.40  $162.19 $704.33 $100.10 $292 -$64, $687  $193 0.134   4   
Alberta
$1,194.14  $214.38 $800.75 $122.83 $393 -$73, $898 $248 0.111   3 
 
Notes: 
1. Positive value favors less costly ‘tight’ group  
 
